Admerex Fpo News - ADL

FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

TUSTIN, Calif., Sept. 18 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major assets in...

AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.

TUSTIN, Calif., Aug. 20 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL Inc. Announces Second Quarter 2009 Financial Results

TUSTIN, Calif., Aug. 19 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL Inc. Files Notification of Late Filing for Form 10-Q

TUSTIN, Calif., Aug. 14 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a U.S.-based pharmaceutical company with major operations...

AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009

Company's VP of Scientific Oversight to present AMDL's Onko-Sure(TM) in vitro diagnostic cancer test to conference attendees TUSTIN, Calif., July...

AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test

TUSTIN, Calif., July 8 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009

TUSTIN, Calif., June 17 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes

TUSTIN, Calif., June 15 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL, Inc. Announces First Quarter 2009 Financial Results

TUSTIN, Calif., May 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer

TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Admerex Fpo (ADL)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

ADL News

FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.

AMDL Inc. Announces Second Quarter 2009 Financial Results

AMDL Inc. Files Notification of Late Filing for Form 10-Q

AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009

AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009

AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes

AMDL, Inc. Announces First Quarter 2009 Financial Results

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer

AMDL Inc.'s JJB Plant Receives Production Approval From Chinese State Food and Drug Administration (SFDA)

AMDL Inc. Announces First Closing of Private Placement of 12% Series Two Senior Notes

AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test

Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets

ADL Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Admerex Fpo (ADL) News

Admerex Fpo (ADL)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

ADL News

FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US

AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.

AMDL Inc. Announces Second Quarter 2009 Financial Results

AMDL Inc. Files Notification of Late Filing for Form 10-Q

AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009

AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test

AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009

AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes

AMDL, Inc. Announces First Quarter 2009 Financial Results

AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer

AMDL Inc.'s JJB Plant Receives Production Approval From Chinese State Food and Drug Administration (SFDA)

AMDL Inc. Announces First Closing of Private Placement of 12% Series Two Senior Notes

AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test

Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets

ADL Discussion

Your Recent History